Phase 2 Ingredient May Aid Weight Loss
Wu X et al., “Enhanced weight loss from a dietary supplement containing standardized Phaseolus vulgaris extract in overweight men and women,” Journal of Applied Research, vol. 10, no. 2 (2010): 73-79.A 60-day, randomized, double-blind, placebo-controlled study investigated the weight-loss effects of Phase 2 Carb Controller, an ingredient by Pharmachem Laboratories (Kearny, NJ) extracted from white kidney bean (Phaseolus vulgaris).
Wu X et al., “Enhanced weight loss from a dietary supplement containing standardized Phaseolus vulgaris extract in overweight men and women,” Journal of Applied Research, vol. 10, no. 2 (2010): 73-79.
A 60-day, randomized, double-blind, placebo-controlled study investigated the weight-loss effects of Phase 2 Carb Controller, an ingredient by Pharmachem Laboratories (Kearny, NJ) extracted from white kidney bean (Phaseolus vulgaris).
Subjects comprised a 51-person intervention group and a 50-subject placebo group. Intervention subjects consumed a Phase 2 supplement containing 1000 mg of Phaseolus vulgaris, three times daily. Subjects’ body weight, waist and hip circumference, and blood chemistry values were measured at the start of the study, and at 30 and 60 days into the trial.
The results showed that 47 of the 51 subjects in the intervention group lost weight after two months, compared to 31 subjects in the placebo group. The average weight loss in the supplement group was 1.9 kg compared to a 0.4 kg loss in the placebo group.
“The Phase 2 group lost nearly five times more weight than the placebo group,” noted Mitch Skop, senior director of new product development for Pharmachem. “Waist size also decreased significantly more in the supplement group-1.9 cm versus -0.4 cm-another five-fold difference.”
Phase 2’s weight-loss mechanism is attributed to its alpha-amylase-inhibiting activity. Pharmachem says that Phaseolus vulgaris extract has been shown in vitro to inhibit the activity of alpha-amylase and may help promote weight loss by interfering with the digestion of complex carbohydrates to simple, absorbable sugars-thereby potentially reducing carbohydrate-derived calories.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.
Microalgae extract supports metabolic health and bone mass during diet and exercise routine
April 11th 2024The extract from Microphyt, called PhaeOptim, was shown to complement weight management strategies that include diet and exercise by support bone mass, aerobic capacity, resting heart rate, and blood lipid profiles.
